Clinical Trial: Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis

U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07614321) titled 'Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis' on May 07.

Brief Summary: The goal of this clinical trial is to learn if silodosin works to treat lower urinary tract symptoms (LUTS) in female patients with multiple sclerosis (MS). It will also learn about the effect of the drug on voiding parameters. The main questions it aims to answer are:

Does silodosin improve lower urinary tract symptoms based on questionnaires? Does silodosin change Uroflowmetry parameters in female patients with MS? Researchers will compare silodosin to a placebo (a look-alike substance that contains no drug) to see if silodosin wor...